XM does not provide services to residents of the United States of America.

Bayer sees Intacta2 Xtend GMO seed covering 30% of Brazil's soybeans



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Bayer sees Intacta2 Xtend GMO seed covering 30% of Brazil's soybeans</title></head><body>

SAO PAULO, Oct 3 (Reuters) -Germany's Bayer BAYGn.DE forecasts that some 30% of Brazil's soybean area will be sowed with its genetically modified biotech seed Intacta2 Xtend in the 2024/25 season, doubling the share from the previous crop, a top executive said this week.

The exact share Intacta2 Xtend will reach should be clear only in some two or three weeks after expected rains allow a broad planting in Brazil's soy fields, Bayer's head of regulatory science for Latin America Geraldo Berger told Reuters in an interview on Monday.


WHY IT'S IMPORTANT

Brazil, the world's largest soy producer and exporter, is Bayer's second largest market behind only the United States.


CONTEXT

Bayer's Intacta2 Xtend seed is designed to tolerate herbicides, including glyphosate and dicamba, and protects the plant against caterpillars.

Last year, Bayer had estimated that between 10% to 15% of Brazil's soybean area would be sowed with Intacta2 Xtend - the third generation of the genetically modified soybean - in the 2023/24 season.


KEY QUOTES

Bob Reiter, head of research and development for Bayer's crop science division, said the firm plans to launch a fourth generation of the product in the next 10 years.

"We always have to stay ahead of insect pressure and insect resistance risk and also improve the breadth of insects that we can try to control with biotechnology," he said.



Reporting by Roberto Samora; Writing by Andre Romani Pinto; Editing by Sandra Maler

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.